Scleroderma lung study tracks disease progression
NCT ID NCT03271333
First seen Jan 06, 2026 · Last updated Apr 29, 2026 · Updated 17 times
Summary
This study followed 56 people with systemic sclerosis (scleroderma) who also have a serious lung condition called diffuse infiltrating pneumonia. Researchers measured lung function at 12 and 24 months to see how the disease changes over time and to identify factors that might predict worsening. The goal was to better understand the disease, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AH-HP, Hôpital Saint Antoine
Paris, 75571, France
-
Hôpital Claude Huriez, CHU
Lille, France
Conditions
Explore the condition pages connected to this study.